Skip to Content

Rinvoq Prices, Coupons and Patient Assistance Programs

Rinvoq (upadacitinib) is a member of the antirheumatics drug class and is commonly used for Rheumatoid Arthritis.

Rinvoq Prices

The cost for Rinvoq oral tablet, extended release 15 mg is around $5,522 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Rinvoq is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Rinvoq availability.

This Rinvoq price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Oral Tablet, Extended Release

15 mg Rinvoq oral tablet, extended release
from $5,522.34 for 30 tablet, extended release
Quantity Per unit Price
30 $184.08 $5,522.34

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Rinvoq Coupons and Rebates

Rinvoq offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Rinvoq Complete Savings Card: Eligible commercially insured patients may pay as little as $5 per month per prescription; for additional information contact the program at 800-274-6867.

Applies to:Rinvoq
Number of uses:Per prescription until program expires

Rinvoq Rebate Program: Eligible commercially insured patients may submit prescription receipts for assistance; for additional information contact the program at 800-471-0186.

Applies to:Rinvoq
Number of uses:Per prescription until program expires

Patient Assistance Programs for Rinvoq

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Rinvoq (upadacitinib) Tablet; Extended Release

Provider: myAbbVie Assist for Rinvoq

Elligibility requirements:
  1. Must be uninsured or underinsured
  2. At or below 600% of FPL
  3. FDA-approved diagnosis
  4. Must reside in the US and be under the direct care of a US physician
  5. Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis. Contact program for details.

Applicable drugs:

  • Rinvoq (upadacitinib) Tablet; Extended Release

Provider: Rinvoq Complete Patient Support Program

Elligibility requirements:
  1. May have insurance
  2. Not disclosed
  3. FDA-approved diagnosis
  4. Must be residing in the US or Puerto Rico
  5. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients. Contact program for details.

Applicable drugs:

  • Rinvoq (upadacitinib) Tablet; Extended Release